Anti-aging drug fisetin reverses blood vessel dysfunction in old mice by targeting senescent cells
This week's aging research reveals how cellular cleanup crews break down, why some compounds can restart them, and what happens when our bodies' quality control systems fail.
🩸 Fisetin reverses age-related blood vessel dysfunction in mice
Researchers gave 27-month-old mice (equivalent to ~80-year-old humans) the senolytic drug fisetin at 100 mg/kg/day for 14 days and found it reversed age-related blood vessel problems
The treatment worked by eliminating senescent endothelial cells that were overproducing CXCL12, a inflammatory protein that damages blood vessels
When plasma from old mice was applied to healthy blood vessels, it impaired their function—but fisetin prevented this damage by reducing the toxic "senescence soup" these zombie cells secrete
Why it matters: This study shows that clearing out senescent cells can actually reverse—not just prevent—age-related blood vessel dysfunction, suggesting anti-aging drugs might restore youthful function to aging cardiovascular systems.
Key Findings
🧬 Senescent cells rely on a specific protein to avoid death
Scientists screened 10,480 compounds and found that senescent cells depend heavily on GPX4 (a protein that prevents a type of cell death called ferroptosis) to survive
When researchers blocked GPX4 with targeted drugs, senescent cells died while healthy cells remained largely unaffected
The approach worked across multiple cancer types in mouse models, eliminating senescent tumor cells when combined with standard cancer therapies
🧠 Blood test predicts cardiovascular risk better than age alone
Researchers developed "HemeAge"—a machine learning model using routine blood count data from 53,355 people that predicts biological age more accurately than chronological age
People with "accelerated aging" (predicted age >10 years older than actual age) had 3x higher mortality risk and 37% higher cardiovascular event risk
Those with "resilient aging" (predicted age >10 years younger) had 41% lower mortality and 24% lower cardiovascular risk compared to people aging "normally"
🍇 Gut-friendly diet linked to longer lifespan through slower biological aging
Analysis of 15,810 people showed that higher scores on a "dietary index for gut microbiota" were associated with 9% lower premature death risk and 10% lower overall mortality
The protective effect was partially explained by slower biological aging, measured using three different aging clocks (PhenoAge, KDMAge, and homeostatic dysregulation)
The relationship was linear—meaning even small improvements in gut-supporting nutrition appeared beneficial
🧪 Brain's cleanup system breaks down in two major diseases
Researchers found that chaperone-mediated autophagy (CMA)—a cellular cleanup process—declines with age and contributes to both skeletal muscle disorders and brain degeneration
When CMA fails, damaged proteins accumulate, leading to inflammation and tissue dysfunction
New compounds that can restore CMA function are showing promise in early studies for treating age-related muscle and brain diseases
🔬 AI discovers new Alzheimer's drugs that cross into the brain
Scientists used an AI platform called "DeepDrugDiscovery" to screen compounds that enhance autophagy (cellular cleanup) and can penetrate the blood-brain barrier
Two lead compounds successfully cleared Alzheimer's-related protein clumps and restored memory in worm and mouse models
The AI approach identified drugs that work independently of mTOR (avoiding side effects of current autophagy drugs) while ensuring brain penetration
💊 Senolytic drugs protect fertility from chemotherapy damage
Mice given cyclophosphamide chemotherapy developed premature ovarian failure, but treatment with dasatinib plus quercetin (senolytic drugs) preserved fertility
The senolytic combination cleared damaged cells and restored normal estrous cycles in 60% of treated mice versus only 15% in untreated chemotherapy mice
RNA analysis showed the drugs reduced genes involved in cellular aging while increasing genes associated with reproductive health
Implications
This week's research reveals a common theme: our bodies' quality control systems—from cellular cleanup to senescent cell clearance—are central to healthy aging. The encouraging news is that multiple approaches, from targeted drugs to dietary changes, show promise for restoring these systems and potentially reversing age-related damage rather than just slowing it down.
Studies in this issue
Primary sources used for this newsletter.
- Fisetin Treatment May Reverse Age-Related Blood Vessel Lining Problems Partly Linked to a Harmful Signaling Proteinmain storyAging cell2026-04-23PMID 42021544
- Link between gut-friendly diet, early death, and overall death risk: The role of biological agingkey findingThe journal of nutrition, health & aging2026-04-24PMID 42030815
- Blood markers of aging linked to heart disease risk: machine learning analysis in two groupskey findingAmerican journal of preventive cardiology2026-04-20PMID 42006429
- DeepDrugDiscovery finds substances that boost cell cleaning and can cross into the brain for Alzheimer's diseasekey findingNature biomedical engineering2026-04-24PMID 42032039
- Screening reactive compounds finds a cell death type linked to GPX4 as a weak point in aging cellskey findingNature cell biology2026-04-24PMID 42032311
- Drugs that remove aged cells may ease early ovarian failure caused by cyclophosphamidekey findingEuropean journal of histochemistry : EJH2026-04-21PMID 42011821
- Multiple roles of cell cleanup processes in keeping muscles healthykey findingAutophagy2026-04-20PMID 42003010
Continue reading
All Longevity & Aging issuesGet the next Longevity & Aging issue
Seven papers, once a week. Free.